Prognosis of residual axillary disease after neoadjuvant chemotherapy in clinically node-positive breast cancer patients: isolated tumor cells and micrometastases carry a better prognosis than macrometastases
Crossref DOI link: https://doi.org/10.1007/s10549-017-4157-0
Published Online: 2017-02-17
Published Print: 2017-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
van Nijnatten, T. J. A.
Simons, J. M.
Moossdorff, M.
de Munck, L.
Lobbes, M. B. I.
van der Pol, C. C.
Koppert, L. B.
Luiten, E. J. T.
Smidt, M. L.
License valid from 2017-02-17